LOMBARDI THIS WEEK
Week of February 28, 2022
Director’s Blog
Louis M. Weiner
Words Fail

I write this week’s blog on Saturday night. Words fail. I cannot do justice to current events, but I feel that I must lend my voice to the chorus. This is too important.
 
News & Announcements
Nanotechnology Enables Potential Novel Imaging Agent for Early Pancreatic Cancer Detection

Georgetown Lombardi METRO Program member Jill Smith, MD, and scientists at Frederick National Laboratory led by Stephan Stern, PhD, have created a novel imaging agent that, with further development, might detect deadly pancreatic cancer at its earliest, most-treatable stages and thereby improve the prognosis for patients. Read more about this research.

Monday, March 21 - Friday, March 25
Afternoons in The Research Building
In-person and hybrid/virtual format, by appointment
 
Please join us for a week of celebrating cancer research with our research and clinical partners through interactive poster discussion sessions. Register and submit your poster title using this form. Registration/poster title submission deadline: Monday, March 7.

Monday, February 28
2:00 - 3:00 p.m.

Gary J. Patti, PhD, Michael and Tana Powell Professor of Chemistry in Arts & Sciences, professor of medicine, and director, Center for Metabolomics and Isotope Tracing, Washington University in St. Louis, presents “Mechanisms for Co-opting Healthy Tissue Metabolism to Drive Tumor Growth.” Sponsored by the Center for Metabolomic Studies. Join this seminar via Zoom.

RESCHEDULED: Tuesday, March 1
4:00 - 5:00 p.m.

Jonathan Schneck, MD, PhD, professor, Department of Pathology, Johns Hopkins Translational Immunology, JH-TIE, Director, The Johns Hopkins Institute for Cell Engineering, presents “Engineering Artificial Antigen Presenting Cells, aAPC, for Cancer Immunotherapy: From Bench to Bedside.” Sponsored by the Office of the Dean for Research. Join the Dean’s Seminar via Zoom.

Friday, March 4
12:00 - 1:00 p.m.

Alexander (Sasha) Gusev, PhD, assistant professor, medicine, Harvard Medical School and Dana-Farber Cancer Institute, presents “Harnessing Off-target Reads from Thousands of Sequenced Tumors to Identify Germline-Somatic Interactions That Influence Patient Outcomes.” Join the lecture via Zoom.

Friday, March 4
12:00 - 1:00 p.m.

Federico Asch, MD, director of cardiovascular core laboratories, MedStar Health Research Institute, professor of medicine, Georgetown University, presents “A Collaborative Model to Answer Questions of Global Interest in Cardiac Ultrasound: The World Alliance Societies of Echocardiography.” Co-sponsored by GHUCCTS and MedStar Health Research Institute. Join the Grand Rounds via Zoom.

Tuesday, March 8
12:00 - 1:00 p.m.

Haiyan He, PhD, assistant professor in the Department of Biology at Georgetown University and a GHUCCTS KL2 scholar, presents “Too Many NEW Cooks Spoil the Broth? A Novel Nascent Protein-Degradation-Based Mechanism for Fast Homeostatic Control of Neuronal Activity.” Register for this Zoom event.
CDI Seminar Virtual Presentation

Tuesday, March 8
3:00 - 4:00 p.m.

Binfeng Lu, PhD, professor, Department of Immunology at University of Pittsburgh School of Medicine, member, University of Pittsburgh Cancer Institute, presents “Tissue Alarmin Cytokines as a Novel Cancer Immunotherapy.” Join this seminar via Zoom.
In the News
Publications
Funding and Award Opportunities

Gilead and Kite Research Scholarships in Oncology

Gilead Sciences and Kite Research Scholars Programs support innovative research from early career investigators around the world to advance scientific knowledge in areas of unmet medical need and improve the lives of patients everywhere. The Research Scholars Program offerings in the fields of hematology and oncology are designed to support innovative basic, translational, and/or clinical research projects in hematologic malignancies and solid tumors. Each award is funded up to $130,000 for two years, to be paid in annual installments of up to $65,000 USD per year. Junior faculty and early career scientists from the United States and Canada are eligible to apply. Gilead and Kite currently offer two Research Scholars Programs in oncology:
_______________________________

Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP) is a two-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Awardees receive $120K/year for two years; requires at least 40% of the scholar’s time. View more information. LOI deadline extended to March 15 at 11:59 p.m. ET.
_______________________________

MDS Research Fund

The Vera and Joseph Dresner Foundation founded the MDS Research Fund to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders. The foundation is now accepting Letters of Inquiry for its 6th annual MDS Research Fund. A total of three new grants, two Early Career Awards and one Established Investigator Award, will be awarded.
  • Early Career Investigator Awards will provide funding of up to $125,000 per year for two years
  • Established Investigator Awards will provide funding of up to $250,000 per year for two years.
The deadline is March 18 at 3:00 p.m. EDT. Visit the foundation’s website for full description and guidelines.
Upcoming Events
Meetings in italics should be attended by all fellows.
Monday
8:00 AM | Monday Morning Oncology Report | Podium A / Microsoft Teams

8:30 AM | Division Weekly Update Meeting | Podium A / Microsoft Teams

9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)

11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)

12:15 PM | Mike Cook and Dr. Noel – Onc Path Conference | Podium A / Microsoft Teams

4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
Tuesday
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)

12:15 PM | ONC ITE | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)

5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
Wednesday
8:00 AM | Thoracic Tumor Board Thoracic Fellow | Podium A / Zoom

9:00 AM | Thoracic Research Meeting Thoracic Fellow | Podium A / Microsoft Teams

12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams

12:15 PM | Dr. Barac – Cardiac Function and HER 2/Anthracycline Treatment | Podium A / Zoom (dial 646-558-8656; Meeting ID: 81006565631)

5:00 PM | GI Tumor Board | Podium A / Microsoft Teams
Thursday
9:00 AM | Cancer Research Data Meeting | Speaker: TBD | Zoom

9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams

12:15 PM | Moved to Friday | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
Friday
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)

12:00 PM | Oncology Grand Rounds Lecture Series: Alexander (Sasha) Gusev, PhD | “Harnessing Off-target Reads from Thousands of Sequenced Tumors to Identify Germline-Somatic Interactions That Influence Patient Outcomes” | Zoom

12:15 PM | Dr. Jain – Research at VA | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

1:00 PM | Pancreas Tumor Board | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
Connect with Georgetown Lombardi on Social Media

If you would like to share news or updates from your department, please get in touch with Sarah Riehl.